Abstract:Preeclampsia remains a major cause of maternal and fetal morbidity and mortality, affecting 2% to 5% of pregnancies. 1 Many studies have shown this disorder has consequences that last decades after pregnancy, with an increased risk of cardiovascular and kidney morbidity and mortality in individuals with a history of preeclampsia. 2 ,3 Recently, those with preeclampsia were described as having a 3-fold higher risk of late-onset vascular dementia after a mean follow-up of 20 years. 4 This cohort study investigated whether preeclampsia and other hypertensive disorders of pregnancy (HDPs) were associated with an increased risk of young-onset dementia years after the pregnancy. Data were obtained from the Conception study, a nationwide prospective cohort study using data from the French National Health Insurance Information System. This database included all deliveries in France after 22 weeks' gestation between January 1, 2010, and December 31, 2018. The French National Public Health Agency has permanent access to the pseudonymized health care reimbursement data in application of the provisions of the French Public Health Code and authorization to perform studies from the French Data Protection Authority, with rules and criteria similar to the Declaration of Helsinki. The French Data Protection Authority approved this study and waived the informed consent requirement because it used anonymized data. All individuals aged 30 years or older without a history of dementia were identified and followed-up from delivery to December 31, 2021. Hazard ratios (HRs) were calculated using crude and adjusted Cox proportional hazards regression models. In all models, exposures to HDPs were treated as time-varying variables and maternal age as a time scale. Models were adjusted for obesity, diabetes, tobacco smoking, drug or alcohol addiction, and social deprivation. Data analysis was performed between March and July 2023 using SAS Enterprise Guide 7.1 (SAS). Of the 1 966 323 individuals (mean [SD] maternal age, 34.6 [3.3] years) included, 128 (<1%) developed dementia. Dementia was identified using primary diagnosis for hospitalization during a mean (SD) follow-up of 9.0 (2.6) years. Patients who developed young-onset dementia were older (36.4 years vs 34.6 years), were more frequently socially deprived (13.3% vs 12.0%), were smokers (14.8% vs 9.0%), and had diabetes (2.3% vs 0.7%) compared with those without dementia (Table 1). Preeclampsia was associated with an increased risk of young-onset dementia compared with pregnancy without HDP (HR, 2.65; 95% CI, 1.34-5.25) (Table 2). Risk of young-onset dementia was even higher when preeclampsia occurred before 34 weeks' gestation (HR, 4.15; 95% CI, 1.30-13.14) or was superimposed on chronic hypertension (HR, 4.76; 95% CI, 1.49-15.22). In contrast, severe preeclampsia was not associated with young-onset dementia. Although earlier studies have already reported cognitive function impairment and white matter lesions associated with preeclampsia, the present study is the first to show an increase in early-onset dementia risk. 5 The results suggested a dose-dependent association, with higher HRs for early-onset preeclampsia and superimposed preeclampsia. The nonsignificant result regarding severe preeclampsia could be associated with the low statistical power in this subgroup, adding to the currently limited knowledge about risk factors of young-onset dementia. 6 A study limitation was that the identification of dementia by hospital diagnosis may have substantially underestimated the incidence of this disease. More studies are needed to confirm these initial findings and to ascertain whether preeclampsia is an independent risk factor for dementia and whether preeclampsia and young-onset dementia share common risk factors or a physiological susceptibility to dementia unmasked by pregnancy. The results add early-onset preeclampsia to the list of lifelong disease risks or health care implications of having had preeclampsia. Accepted for Publication: March 6, 2024. Published: May 30, 2024. doi:10.1001/jamanetworkopen.2024.12870 Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2024 Olié V et al. JAMA Network Open . Corresponding Author: Valérie Olié, PhD, Santé publique France, 12 rue du Val d'Osne, 94415 Saint-Maurice cedex, France (valérie.olie@santepubliquefrance.fr). Author Contributions: Drs Olié and Lailler had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Concept and design: Olié, Lailler, Carcaillon-Bentata, Blacher. Acquisition, analysis, or interpretation of data: All authors. Drafting of the manuscript: Olié. Critical revie -Abstract Truncated-

Early-onset vs late-onset preeclampsia and risk of coronary atherosclerosis later in life: a clinical follow-up study

Body mass index, lipid profile, and endothelial dysfunction gene polymorphism in women with early-onset and late-onset preeclampsia

Pregnancy Outcome in Early versus Late Onset Preeclampsia

Early- and Late-Onset Preeclampsia: A Comprehensive Cohort Study of Laboratory and Clinical Findings according to the New ISHHP Criteria

The Feto-Maternal Outcomes and Incidence of Early-and Late-Onset Preeclampsia

Left Ventricular Hypertrophy in Women With a History of Preeclampsia

Early Onset of Coronary Artery Calcification in Women With Previous Preeclampsia

Abstract 18: Impact of Preeclampsia on Cardiovascular Risk Factors in Mothers and Newborns

Clinical presentation, maternal-fetal, and neonatal outcomes of early-onset versus late onset preeclampsia-eclampsia syndrome in a teaching hospital in a low-resource setting: A retrospective cohort study

Young-Onset Dementia Among Individuals With History of Preeclampsia

Cardiovascular Disease Risk Factors After Early-Onset Preeclampsia, Late-Onset Preeclampsia, and Pregnancy-Induced Hypertension

Preeclampsia-Associated Cardiovascular Risk Factors 6 Months and 2 Years After Pregnancy: The P4 Study

[Clinical features and prognosis of early-onset preeclampsia].

Women With a History of Preeclampsia Exhibit Accelerated Aging and Unfavorable Profiles of Senescence Markers

Ri sk factors fo recurrent preeclampsia and i ts relation ot mta ernal and fo fspring outcome

Soluble fms-Like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies

Clinical Course, Associated Factors, and Blood Pressure Profile of Delayed-Onset Postpartum Preeclampsia

Metabolic outcomes in women 6 months and 2 years after preeclampsia versus normotensive pregnancy: A P4 study

Multiplex Analysis of Circulating Maternal Cardiovascular Biomarkers Comparing Preeclampsia Subtypes

Preeclampsia and cognitive impairment later in life

Association between preeclampsia and long-term risk of arrhythmias